EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic.

ABSTRACT:

Background and purpose

The recent SARS-CoV-2 pandemic has posed multiple challenges to the practice of clinical neurology including recognition of emerging neurological complications and management of coexistent neurological diseases. In a fast-evolving pandemic, evidence-based studies are lacking in many areas. This paper presents European Academy of Neurology (EAN) expert consensus statements to guide neurologists caring for patients with COVID-19.

Methods

A refined Delphi methodology was applied. In round 1, statements were provided by EAN scientific panels (SPs). In round 2, these statements were circulated to SP members not involved in writing them, asking for agreement/disagreement. Items with agreement >70% were retained for round 3, in which SP co-chairs rated import

SUBMITTER: von Oertzen TJ 

PROVIDER: S-EPMC7675361 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature